Ilkley, United Kingdom

Robert Edward Tully

This inventor holds 2 USPTO granted patents. Top assignee: Akzo Nobel N.v.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Edward Tully. Retrieved from https://idiyas.com/inventor/robert-edward-tully

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Robert Edward Tully

Introduction

Robert Edward Tully is a notable inventor based in Ilkley, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral liquid antidepressant solutions. With a total of 2 patents to his name, Tully's work focuses on improving the administration of antidepressant medications.

Latest Patents

Tully's latest patents include an innovative oral liquid antidepressant solution designed for the administration of the anti-depressant mirtazapine. This formulation is an aqueous solution or suspension that is preferably stabilized by methionine and thickened, with a pH ranging from 2.5 to 3. The invention aims to avoid the undesirable local anesthetic effect associated with mirtazapine, enhancing the overall efficacy and patient experience.

Career Highlights

Robert Edward Tully is associated with Akzo Nobel N.V., a leading company in the field of chemicals and pharmaceuticals. His work at the company has allowed him to focus on developing solutions that address critical needs in mental health treatment.

Collaborations

Tully collaborates with Arnold Titus Skrabanja, contributing to the advancement of pharmaceutical innovations. Their partnership exemplifies the importance of teamwork in the field of research and development.

Conclusion

Robert Edward Tully's contributions to the pharmaceutical industry, particularly through his patents on oral liquid antidepressant solutions, highlight his commitment to improving mental health treatments. His work continues to influence the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…